136 related articles for article (PubMed ID: 2124009)
1. Lymphocyte subset populations in bronchiolitis obliterans after heart-lung transplantation.
Holland VA; Cagle PT; Windsor NT; Noon GP; Greenberg SD; Lawrence EC
Transplantation; 1990 Dec; 50(6):955-9. PubMed ID: 2124009
[TBL] [Abstract][Full Text] [Related]
2. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
[TBL] [Abstract][Full Text] [Related]
3. [Graft dysfunction, acute rejection and bronchiolitis obliterans in lung and heart-lung transplantation].
Sleiman C; Groussard O; Mal H; Fournier M
Rev Mal Respir; 1996 Nov; 13(5 Suppl):S31-40. PubMed ID: 9011909
[TBL] [Abstract][Full Text] [Related]
4. Lung T-Cell Profile Alterations are Associated with Bronchiolitis Obliterans Syndrome in Cystic Fibrosis Lung Transplant Recipients.
Hayes D; Harhay MO; Nicol KK; Liyanage NPM; Keller BC; Robinson RT
Lung; 2020 Feb; 198(1):157-161. PubMed ID: 31807920
[TBL] [Abstract][Full Text] [Related]
5. Bronchiolitis obliterans following heart-lung and lung transplantation.
Kramer MR
Respir Med; 1994 Jan; 88(1):9-15. PubMed ID: 8029521
[No Abstract] [Full Text] [Related]
6. Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation.
Zheng L; Orsida B; Whitford H; Levvey B; Ward C; Walters EH; Williams TJ; Snell GI
Transplantation; 2005 Jul; 80(2):185-92. PubMed ID: 16041262
[TBL] [Abstract][Full Text] [Related]
7. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
[TBL] [Abstract][Full Text] [Related]
8. Preferential production of IgG2 antibodies by parenchymal lung B-lymphocytes during lung allograft rejection.
Wilkes DS; Sidner RA; Mathur PN; Niemeier M; Schwenk R; Heidler KM; Bowen LK
Transplant Proc; 1997 May; 29(3):1891-5. PubMed ID: 9142313
[No Abstract] [Full Text] [Related]
9. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
10. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.
Hasegawa S; Ockner DM; Ritter JH; Patterson GA; Trulock EP; Cooper JD; Wick MR
Arch Pathol Lab Med; 1995 May; 119(5):432-9. PubMed ID: 7748071
[TBL] [Abstract][Full Text] [Related]
11. The two forms of bronchiolitis obliterans in heart-lung transplant recipients.
Abernathy EC; Hruban RH; Baumgartner WA; Reitz BA; Hutchins GM
Hum Pathol; 1991 Nov; 22(11):1102-10. PubMed ID: 1743693
[TBL] [Abstract][Full Text] [Related]
12. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.
White SR; Floreth T; Liao C; Bhorade SM
PLoS One; 2014; 9(7):e103643. PubMed ID: 25068264
[TBL] [Abstract][Full Text] [Related]
13. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?
Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz MI
Transplantation; 1993 May; 55(5):1040-4. PubMed ID: 7684535
[TBL] [Abstract][Full Text] [Related]
14. Experimental large-animal model of obliterative bronchiolitis after lung transplantation.
al-Dossari GA; Kshettry VR; Jessurun J; Bolman RM
Ann Thorac Surg; 1994 Jul; 58(1):34-9; discussion 39-40. PubMed ID: 8037556
[TBL] [Abstract][Full Text] [Related]
15. Early lung leukocyte infiltration, HLA and adhesion molecule expression predict chronic rejection.
Devouassoux G; Pison C; Drouet C; Pin I; Brambilla C; Brambilla E
Transpl Immunol; 2001 Feb; 8(4):229-36. PubMed ID: 11316065
[TBL] [Abstract][Full Text] [Related]
16. Particular phenotypic profile of blood lymphocytes during obliterative bronchiolitis syndrome following lung transplantation.
Fattal-German M; Frachon I; Cerrina J; Ladurie FL; Lecerf F; Dartevelle P; Berrih-Aknin S
Transpl Immunol; 1994 Sep; 2(3):243-51. PubMed ID: 7528088
[TBL] [Abstract][Full Text] [Related]
17. Bronchiolitis obliterans syndrome after heart-lung transplantation: a case report and review of literature.
Sittpunt C; Wongtim S; Udompanich V; Kaewkittinarong K; Luengtaviboon K
J Med Assoc Thai; 2004 Jun; 87(6):713-6. PubMed ID: 15279355
[TBL] [Abstract][Full Text] [Related]
18. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
[TBL] [Abstract][Full Text] [Related]
19. MHC class II and ICAM-1 expression and lymphocyte subsets in transbronchial biopsies from lung transplant recipients.
Milne DS; Gascoigne AD; Wilkes J; Sviland L; Ashcroft T; Malcolm AJ; Corris PA
Transplantation; 1994 Jun; 57(12):1762-6. PubMed ID: 7912458
[TBL] [Abstract][Full Text] [Related]
20. Lung transplantation: opportunities for research and clinical advancement.
Magro CM; Pope-Harman AL; Abbas AE; Ross P
Am J Respir Crit Care Med; 2006 Feb; 173(4):466-7; author reply 467. PubMed ID: 16467179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
